US Patent No 7135195
Treatment of human beings with the New Colloidal Silver Solution

This page summarises parts of the US Patent No 7135195, which was awarded by the US Patent Office to American Biotech Labs on 14 Nov 2006 for their new colloidal silver solution.  The full patent is available on the US Patent Office website.  The US Patent Office has very exacting standards requiring strong evidence to support any claims made.  As this is the first patent to be granted for any Colloidal Silver since 1924  and the claims made by this patent have been accepted by the US Patent Office, it confirms that the American Biotech Labs colloidal silver solution is the most advanced colloidal silver solution in the world.

Abstract

The patent abstract describes the new colloidal silver solution as being a colorless composition made up of silver particles and water.  The silver particles have an interior of elemental silver whilst the exterior comprises of ionic silver oxide.  These silver particles are at a concentration of about 5 to 40 parts per million (ppm) and create a significant antimicrobial properties.

 
Claims

 The Staphylococcus aureus mentioned above is methicillin resistant (better known as MRSA).

It also exhibited antimicrobial properties against another group of microbes associated with the following diseases: tonsillitis, vaginal infections, gonorrhea, malaria, urinary tract infections, pelvic inflammatory disease, pharyngitis, bacterial infections of the skin, conjunctivitis, nasal infections, respiratory tract infections, otitis, and fungal infections of the skin.

Additional to the antimicrobial properties are antiviral properties including from a group consisting of hepatitis and HIV.  Furthermore these antiviral properties of this colloidal silver solution include inhibiting viral DNA polymerase and viral reverse transcriptase. 

 

Pathogens/human diseases killed by this new Colloidal Silver Solution

The following list from the patent shows the actual concentration of the new colloidal silver solution required to kill pathogens/cure diseases.  Remember that this is based actual trail data accepted by the US Patent Office.  You will note the concentrations are very low, the highest being just 10 parts (of silver) per million (ppm):

At 5.0 ppm Staphylococcus aureus was killed
At 5.0 ppm Osteomyelitis Staphylococcus aureus was killed 
At 2.5 ppm Bacillary Dysentery Shigella boydii was killed
At 5.0 ppm Burn Infections Pseudomonas aeruginosa was killed
At 5.0 ppm Dental Plaque Streptococcus mutans was killed
At 2.5 ppm Diarrhea (Bloody) Shigella boydii was killed
At 2.5 ppm Diarrhea Escherichia coli was killed
At 1.25 ppm Ear Infection Haemophilus influenzae was killed
At 2.5 ppm Ear Infection Streptococcus pneumonie was killed
At 2.5 ppm Enteric Fever Salmonella tyhimurium was killed
At 1.25 ppm Epiglottitis (In children) Haemophilus influenzae was killed
At 5.0 ppm Eye Infections Staphylococcus aureus was killed
At 5.0 ppm Corneal Ulcers-Keratitis Pseudomonas aeruginosa was killed
At 5.0 ppm Food Poisoning Salmonella arizona was killed
At 2.5 ppm Food Poisoning Salmonella tyhimurium was killed
At 2.5 ppm Food Poisoning Escherichia coli was killed
At 2.5 ppm Endocarditis Streptococcus faecalis was killed
At 5.0 ppm Endocarditis Streptococcus gordonii was killed
At 1.25 ppm Meningitis Haemophilus influenzae was killed
At 2.5 ppm Meningitis Enterobacter aerogenes was killed
At 5.0 ppm Meningitis Pseudomonas aeruginosa was killed
At 2.5 ppm Meningitis Streptococcus pneumonie was killed
At 2.5 ppm Nosocomial Infections Klebsiella pneumoniae was killed
At 5.0 ppm Nosocomial Infections Pseudomonas aeruginosa was killed
At 1.25 ppm Nosocomial Infections (From Streptococcus pyogenes) was killed
At 5.0 ppm Pneumonia Staphylococcus aureus was killed
At 1.25 ppm Pneumonia Haemophilus influenzae was killed
At 5.0 ppm Pneumonia Pseudomonas aeruginosa was killed
At 2.5 ppm Pneumonia Streptococcus pneumonie was killed
At 1.25 ppm Respiratory Tract Infections Streptococcus pyogenes was killed
At 2.5 ppm Respiratory Tract Infections E. coli was killed
At 2.5 ppm Respiratory Tract Infections Klebsiella pneumoniae was killed
At 1.25 ppm Scarlet Fever Streptococcus pyogenes was killed
At 2.5 ppm Septicemia Enterobacter aerpyogenes was killed
At 1.25 ppm Sinus Infections Haemophilus influenzae was killed
At 2.5 ppm Sinusitis Streptococcus pneumonie was killed
At 1.25 ppm Impetigo Staphylococcus aureus was killed
At 5.0 ppm Skin Infections Staphylococcus aureus was killed
At 1.25 ppm Skin Infections Streptococcus pyogenes was killed
At 1.25 ppm Strep Throat Streptococcus pyogenes was killed
At 1.25 ppm Suppurative Arthritis Haemophilus influenzae was killed
At 1.25 ppm Throat Infections Haemophilus influenzae was killed
At 5.0 ppm Tooth Decay Streptococcus mutans was killed
At 10.0 ppm Urethritis (Men) Trichomonas vaginalis was killed
At 2.5 ppm Urinary Tract Infections E. coli was killed
At 2.5 ppm Urinary Tract Infections Klebsiella pneumoniae was killed
At 5.0 ppm Urinary Tract Infections Pseudomonas aeruginosa was killed
At 2.5 ppm Urinary Tract Infections Streptococcus faecalis was killed
At 2.5 ppm Urinary Tract Infections Enterobacter aerpyogenes was killed
At 10.0 ppm Vaginitis (Women) Trichomonas vaginalis was killed
At 2.5 ppm Wound Infections Escherichia coli was killed
At 2.5 ppm Wound Infections Enterobacter aerpyogenes was killed
At 2.5 ppm Wound Infections Klebsiella pneumoniae was killed
At 5.0 ppm Wound Infections Pseudomonas aeruginosa was killed
At 2.5 ppm Wound Infections Streptococcus faecalis was killed
At 10.0 ppm Yeast Infections Candida albicans was killed

ORDER NOW            BLOG


Home        Video Presentation        History of Silver/Health        Testimonials        Scientific Validation


Homeland Security        EPA Validation        US Patent        About Me        Contact Me        Bookshop


Disclaimer        Links        Guestbook        Affiliate Program      Spam Policy      Privacy Policy       Banner